Holen Sie sich die Stockscreener-App
18.56
4.09%
0.73
Vorhandelsmarkt:
18.36
-0.20
-1.08%
Schlusskurs vom Vortag:
$17.83
Offen:
$17.62
24-Stunden-Volumen:
12.57M
Relative Volume:
3.09
Marktkapitalisierung:
$4.04B
Einnahmen:
$10.68M
Nettoeinkommen (Verlust:
$-272.71M
KGV:
-11.86
EPS:
-1.565
Netto-Cashflow:
$-213.38M
1W Leistung:
+16.88%
1M Leistung:
+30.98%
6M Leistung:
+116.82%
1J Leistung:
+459.04%
1-Tages-Spanne:
$17.62
$18.75
1-Wochen-Bereich:
$16.14
$18.94
52-Wochen-Spanne:
$3.025
$18.94
Relay Therapeutics Inc Stock (RLAY) Company Profile
Firmenname
Relay Therapeutics Inc
Sektor
Branche
Telefon
617-370-8837
Adresse
60 HAMPSHIRE STREET, CAMBRIDGE
Compare RLAY vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
18.56 | 4.04B | 10.68M | -272.71M | -213.38M | -1.565 |
VRTX
Vertex Pharmaceuticals Inc
|
491.34 | 124.70B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
632.90 | 66.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
887.18 | 55.17B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
291.37 | 38.90B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
182.08 | 38.71B | 742.00K | -1.37B | -1.07B | -7.0731 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-26 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-12-12 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-09-04 | Fortgesetzt | Guggenheim | Buy |
| 2025-04-17 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-09-10 | Fortgesetzt | Goldman | Buy |
| 2024-09-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-09-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-05-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-04-20 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-04-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | Eingeleitet | Raymond James | Outperform |
| 2023-02-03 | Eingeleitet | Oppenheimer | Outperform |
| 2022-09-30 | Eingeleitet | Barclays | Equal Weight |
| 2022-09-02 | Eingeleitet | Stifel | Buy |
| 2022-06-06 | Eingeleitet | Jefferies | Underperform |
| 2022-02-01 | Eingeleitet | Berenberg | Buy |
| 2021-07-21 | Eingeleitet | BofA Securities | Buy |
| 2020-12-15 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-11-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-08-10 | Eingeleitet | Cowen | Outperform |
| 2020-08-10 | Eingeleitet | Goldman | Buy |
| 2020-08-10 | Eingeleitet | Guggenheim | Buy |
| 2020-08-10 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten
Why Is RLAY Stock Rising Today? - Stocktwits
RLAY stock declines pre-market after $175M offering — despite fresh bullish calls on Relay's zovegalisib - MSN
Relay Therapeutics, Inc. Actuals & Estimates (NASDAQ:RLAY) - TradingView
RLAY Forecast — Price Target — Prediction for 2027 - TradingView
Relay Therapeutics Stock Rockets 34% With 9-Day Winning Streak - Trefis
Relay Therapeutics (RLAY) Short Interest & Short Float | Updated Jun 2026 $RLAY - MarketBeat
Relay Therapeutics (RLAY) Stock Analysis Report | Ratings, Financials & Performance - Benzinga España
Form 4 Relay Therapeutics Inc For: 24 June By Investing.com - Investing.com Nigeria
Relay Therapeutics president R&D sells $1.58m in stock By Investing.com - Investing.com Nigeria
Relay Therapeutics president R&D sells $1.58m in stock - Investing.com
Relay Therapeutics (RLAY) R&D chief exercises options and sells 93K shares - Stock Titan
Relay Therapeutics (NASDAQ: RLAY) CFO sells 187,163 shares after exercising options - Stock Titan
8-Day Rally Sends Relay Therapeutics Stock Up 29% - Trefis
Relay Therapeutics stock hits 52-week high at 17.54 USD - Investing.com UK
Relay Therapeutics stock hits 52-week high at 17.54 USD By Investing.com - Investing.com South Africa
Form 144 RELAY THERAPEUTICS For: 22 June By Investing.com - Investing.com Australia
Form 144 | Relay Therapeutics(RLAY.US) Officer Proposes to Sell 3.25 Million in Common Stocks - Moomoo
Donald A. (RLAY) files Form 144 to sell 93,456 shares on 06/22/2026 - Stock Titan
RLAY: Director Thomas Catinazzo executed 4 10b5-1 sales (Apr–May 2026) - Stock Titan
Relay Therapeutics StockAnalyst views and long-term strategy in focus - Ad-hoc-news.de
Analysts Are Bullish on These Healthcare Stocks: BrightSpring Health Services, Inc. (BTSG), Relay Therapeutics (RLAY) - The Globe and Mail
Top Smidcap Pick: TD Cowen Highlights Relay Therapeutics By Investing.com - Investing.com South Africa
Relay Therapeutics Inc (RLAY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Relay Therapeutics Inc (RLAY) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Relay Therapeutics Inc (RLAY) Institutional Confidence - TradingKey
Relay Therapeutics Inc (RLAY) Valuation: PE, PB & Fair Value Analysis - TradingKey
Relay Therapeutics Inc (RLAY) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Relay Therapeutics Inc (RLAY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Relay Therapeutics Inc (RLAY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Relay Therapeutics Inc (RLAY) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Relay Therapeutics Q1 2026 earnings preview - MSN
Number of shareholders of Relay Therapeutics, Inc. – NASDAQ:RLAY - TradingView
Relay Therapeutics (RLAY) is One of the Best AI Driven Biotech Stocks, Here is Why - Insider Monkey
Relay Therapeutics Expands Authorized Shares at 2026 Meeting - The Globe and Mail
[Form 4] Relay Therapeutics, Inc. Insider Trading Activity - Stock Titan
Relay Therapeutics (RLAY) director granted options on 32,947 shares at $14.09 - Stock Titan
10 Best AI Driven Biotech Stocks to Invest In - Insider Monkey
Relay Therapeutics (NASDAQ: RLAY) ups authorized common stock to 450M - Stock Titan
Relay Therapeutics prices $275M public offering of common stock at $12/share - MSN
RLAY News | RELAY THERAPEUTICS INC (NASDAQ:RLAY) - ChartMill
Analysts Offer Insights on Healthcare Companies: Replimune Group (REPL), Eli Lilly & Co (LLY) and Relay Therapeutics (RLAY) - The Globe and Mail
RLAY stock lights up on vascular anomalies treatment data boost – 60% of patients show sharp reduction in lesion volume - MSN
RLAY Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Relay Therapeutics Hits Day High with 10.1% Surge in Strong Intraday Performance - Markets Mojo
Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):